124 related articles for article (PubMed ID: 11105897)
21. Alternative splicing removes an Ets interaction domain from Lozenge during Drosophila eye development.
Jackson Behan K; Fair J; Singh S; Bogwitz M; Perry T; Grubor V; Cunningham F; Nichols CD; Cheung TL; Batterham P; Pollock JA
Dev Genes Evol; 2005 Aug; 215(8):423-35. PubMed ID: 15868204
[TBL] [Abstract][Full Text] [Related]
22. Mutagenesis of the Runt domain defines two energetic hot spots for heterodimerization with the core binding factor beta subunit.
Zhang L; Li Z; Yan J; Pradhan P; Corpora T; Cheney MD; Bravo J; Warren AJ; Bushweller JH; Speck NA
J Biol Chem; 2003 Aug; 278(35):33097-104. PubMed ID: 12807883
[TBL] [Abstract][Full Text] [Related]
23. Patterning of cells in the Drosophila eye by Lozenge, which shares homologous domains with AML1.
Daga A; Karlovich CA; Dumstrei K; Banerjee U
Genes Dev; 1996 May; 10(10):1194-205. PubMed ID: 8675007
[TBL] [Abstract][Full Text] [Related]
24. Runt and Lozenge function in Drosophila development.
Canon J; Banerjee U
Semin Cell Dev Biol; 2000 Oct; 11(5):327-36. PubMed ID: 11105896
[TBL] [Abstract][Full Text] [Related]
25. Lineage- and stage-specific expression of runt box polypeptides in primitive and definitive hematopoiesis.
Corsetti MT; Calabi F
Blood; 1997 Apr; 89(7):2359-68. PubMed ID: 9116279
[TBL] [Abstract][Full Text] [Related]
26. Functional mutagenesis of AML1/RUNX1 and PEBP2 beta/CBF beta define distinct, non-overlapping sites for DNA recognition and heterodimerization by the Runt domain.
Nagata T; Werner MH
J Mol Biol; 2001 Apr; 308(2):191-203. PubMed ID: 11327761
[TBL] [Abstract][Full Text] [Related]
27. Runx1 expression marks long-term repopulating hematopoietic stem cells in the midgestation mouse embryo.
North TE; de Bruijn MF; Stacy T; Talebian L; Lind E; Robin C; Binder M; Dzierzak E; Speck NA
Immunity; 2002 May; 16(5):661-72. PubMed ID: 12049718
[TBL] [Abstract][Full Text] [Related]
28. Overlapping expression of Runx1(Cbfa2) and Runx2(Cbfa1) transcription factors supports cooperative induction of skeletal development.
Smith N; Dong Y; Lian JB; Pratap J; Kingsley PD; van Wijnen AJ; Stein JL; Schwarz EM; O'Keefe RJ; Stein GS; Drissi MH
J Cell Physiol; 2005 Apr; 203(1):133-43. PubMed ID: 15389629
[TBL] [Abstract][Full Text] [Related]
29. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
30. Fibroblast growth factor controls the timing of Scl, Lmo2, and Runx1 expression during embryonic blood development.
Walmsley M; Cleaver D; Patient R
Blood; 2008 Feb; 111(3):1157-66. PubMed ID: 17942750
[TBL] [Abstract][Full Text] [Related]
31. Altered affinity of CBF beta-SMMHC for Runx1 explains its role in leukemogenesis.
Lukasik SM; Zhang L; Corpora T; Tomanicek S; Li Y; Kundu M; Hartman K; Liu PP; Laue TM; Biltonen RL; Speck NA; Bushweller JH
Nat Struct Biol; 2002 Sep; 9(9):674-9. PubMed ID: 12172539
[TBL] [Abstract][Full Text] [Related]
32. Inability of RUNX1/AML1 to breach AML1-ETO block of embryonic stem cell definitive hematopoiesis.
Peterson LF; Lo MC; Okumura AJ; Zhang DE
Blood Cells Mol Dis; 2007; 39(3):321-8. PubMed ID: 17692541
[TBL] [Abstract][Full Text] [Related]
33. Pathways in blood and vessel development revealed through zebrafish genetics.
Crosier PS; Kalev-Zylinska ML; Hall CJ; Flores MV; Horsfield JA; Crosier KE
Int J Dev Biol; 2002; 46(4):493-502. PubMed ID: 12141436
[TBL] [Abstract][Full Text] [Related]
34. New mechanisms of AML1 gene alteration in hematological malignancies.
Roumier C; Fenaux P; Lafage M; Imbert M; Eclache V; Preudhomme C
Leukemia; 2003 Jan; 17(1):9-16. PubMed ID: 12529654
[TBL] [Abstract][Full Text] [Related]
35. Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene.
Yergeau DA; Hetherington CJ; Wang Q; Zhang P; Sharpe AH; Binder M; Marín-Padilla M; Tenen DG; Speck NA; Zhang DE
Nat Genet; 1997 Mar; 15(3):303-6. PubMed ID: 9054947
[TBL] [Abstract][Full Text] [Related]
36. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis.
Ichikawa M; Asai T; Saito T; Seo S; Yamazaki I; Yamagata T; Mitani K; Chiba S; Ogawa S; Kurokawa M; Hirai H
Nat Med; 2004 Mar; 10(3):299-304. PubMed ID: 14966519
[TBL] [Abstract][Full Text] [Related]
37. Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer.
Sakakura C; Hagiwara A; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Ito K; Yamagishi H; Yazumi S; Chiba T; Ito Y
Int J Cancer; 2005 Jan; 113(2):221-8. PubMed ID: 15386419
[TBL] [Abstract][Full Text] [Related]
38. Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype.
Growney JD; Shigematsu H; Li Z; Lee BH; Adelsperger J; Rowan R; Curley DP; Kutok JL; Akashi K; Williams IR; Speck NA; Gilliland DG
Blood; 2005 Jul; 106(2):494-504. PubMed ID: 15784726
[TBL] [Abstract][Full Text] [Related]
39. A novel inherited mutation of the transcription factor RUNX1 causes thrombocytopenia and may predispose to acute myeloid leukaemia.
Walker LC; Stevens J; Campbell H; Corbett R; Spearing R; Heaton D; Macdonald DH; Morris CM; Ganly P
Br J Haematol; 2002 Jun; 117(4):878-81. PubMed ID: 12060124
[TBL] [Abstract][Full Text] [Related]
40. Runx1/AML-1 ranks as a master regulator of adult hematopoiesis.
Ichikawa M; Asai T; Chiba S; Kurokawa M; Ogawa S
Cell Cycle; 2004 Jun; 3(6):722-4. PubMed ID: 15213471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
